Press Releases - G1 Therapeutics, Inc.

Press Releases

Date	Title
5/23/24	G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
5/22/24	G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit
5/22/24	G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
5/1/24	G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/1/24	G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
5/1/24	G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
4/17/24	G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
4/4/24	G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
4/1/24	G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/1/24	G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)